Rebalix
Logo AvantisAvantis · sheet of 10 September 2026
ETF sheet · official issuer and register data

Avantis Europe Equity UCITS ETF

AVEU · IE000SDFJUU0 · class Class-I Shares · USD · domicile Ireland
Equity · Europe · All sizesactiveSFDR art. 6
Comparison benchmark: MSCI Europe IMI Index
TER
0.25%+ trans. 0.01%
Fund size
27 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Physicalactive management
Income
Accumulating
Launch 9 Feb 2026 · costs from the KID as of 15 Aug 2026 · 1,254 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 15 Aug 2026
Investment objective The investment objective of Avantis Europe Equity UCITS ETF (the "Fund") is to seek long-term capital appreciation through investment in an actively managed portfolio of equity and equity-related securities issued by large, mid and small capitalisation companies in European developed market countries. Investment policies The Fund will seek to achieve its investment objective by investing in a portfolio of equities and equity-related securities, common shares, convertible stock, preferred shares, rights issues, equity warrants which…

Performance since series start (in euro) — base 100

9 Feb 20268 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
10892106
High 108 (14 Aug 2026) · low 92 (20 Mar 2026) · last 106. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+6.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · AVEU · IE000SDFJUU01
RebalixAVEU · IE000SDFJUU0 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 1,254 securities · top-10 weight = 13.9%
Top holdingsWeight
ASML HOLDING NV NY REG SHS NY REG SHRS EUR.093.1%
SHELL PLC ADR ADR1.4%
BANCO BILBAO VIZCAYA SP ADR ADR1.3%
UBS GROUP AG REG COMMON STOCK USD.11.3%
HSBC HOLDINGS PLC SPONS ADR ADR1.2%
ALLIANZ SE REG COMMON STOCK1.2%
ROCHE HOLDING AG COMMON STOCK CHF.0011.2%
ZURICH INSURANCE GROUP AG COMMON STOCK CHF.11.1%
BP PLC SPONS ADR ADR1.1%
NOVARTIS AG SPONSORED ADR ADR1.1%
Countries (% of fund)
United Kingdom23.0%France15.0%Switzerland14.0%Germany13.0%Netherlands9.0%
Sectors (% of fund)
Financials27.0%Industrials21.0%Health Care9.0%Consumer Discretionary8.0%Materials7.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
AVEU · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 10 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · res.avantisinvestors.com/avantis/ucits-etfs/PRIIP-Avantis-Europe-Equit
Factsheet · res.avantisinvestors.com/docs/avantis-europe-equity-ucits-etf-fact-she
Prospectus · res.avantisinvestors.com/avantis/ucits-etfs/American-Century-ICAV-Pros
The live sheet, always up to date
rebalix.com/en/etf/IE000SDFJUU0
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · AVEU · IE000SDFJUU02